The Stock Exchange and stakeholders are requested to take on record the Outcome of the Board Meeting, as attached herewith.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shentracon Chemicals reported audited standalone results for quarter and year ended March 31, 2026. Revenue from operations declined to Rs 4.75 Lakhs in Q4 (vs Rs 7.94 Lakhs in Q4 FY25) and Rs 16.75 Lakhs for full year (vs Rs 17.66 Lakhs). The company posted a loss before tax of Rs 33.35 Lakhs for FY26 versus loss of Rs 29.75 Lakhs in FY25. Loss after tax stood at Rs 33.35 Lakhs with EPS of Rs -0.75. The balance sheet shows negative shareholders' equity of Rs -225.80 Lakhs (Other Equity at Rs -669.61 Lakhs against share capital of Rs 443.81 Lakhs), indicating severe net worth erosion. Total assets are Rs 113.10 Lakhs while borrowings stand at Rs 303 Lakhs. M/s Mark & Co. issued an unmodified (clean) audit opinion. Cash flow from operations was negative at Rs -4.99 Lakhs for FY26.
The company is in significant financial distress with negative net worth and consistent losses. Negative shareholders' equity of over Rs 225 Lakhs raises serious going concern issues despite the clean audit. Shareholders face extreme risk as the company's liabilities exceed assets by a wide margin.